Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001140361-15-037190

Director acquired 1,172,437 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Conti Kurt G · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Owned after D/I
2015-10-06 Conversion : show line 1 in the form +160,810 160,810 D
2015-10-06 Conversion : show line 2 in the form +163,731 324,541 D
2015-10-06 Conversion : show line 3 in the form +29,238 29,238 I
2015-10-06 Conversion : show line 4 in the form +14,619 14,619 I
2015-10-06 Conversion : show line 5 in the form +14,619 14,619 I
2015-10-06 Conversion : show line 6 in the form +789,420 789,420 I

Table II: Derivative

6 lines
Date Transaction Shares Underlying Owned after D/I
2015-10-06 Conversion : show line 7 in the form Series A Convertible Preferred Stock −220,000 160,810 0 D
2015-10-06 Conversion : show line 8 in the form Series B Convertible Preferred Stock −224,000 163,731 0 D
2015-10-06 Conversion : show line 9 in the form Series B Convertible Preferred Stock −40,000 29,238 0 I
2015-10-06 Conversion : show line 10 in the form Series B Convertible Preferred Stock −20,000 14,619 0 I
2015-10-06 Conversion : show line 11 in the form Series B Convertible Preferred Stock −20,000 14,619 0 I
2015-10-06 Conversion : show line 12 in the form Series B Convertible Preferred Stock −1,080,000 789,420 0 I
Loading xslF345X03/doc1.xml…